About UsProductsCareersInvestorsContact UsSearch
Nabi Biopharmaceuticals
Powering the Immune System
Pipeline Overview
Nicotine Addiction
NicVAX®
Gram-Positive Programs
EnteroVAX™
Clinical Trials
 

EnteroVAX™(Enterococcus faecalis Conjugate Vaccine)

 

Enterococcus is a clinically significant Gram-positive bacterium that causes hospital-acquired infections, representing approximately 10-12% of all bloodstream infections. Nabi has identified and patented three polysaccharide antigens that cover both E. faecalis and E. faescium that comprise almost 100% of vancomycin resistant strains.

.


^ Top